Natalie Vokes
@NIVokes
Followers
672
Following
593
Media
9
Statuses
126
Asst professor @MDAndersonNews. Lung cancer and clinical computational oncology. Tweets are my own.
Houston, TX
Joined March 2013
RT @BZhangMD: Important paper put out by stellar MDA colleagues! Congrats to all co- authors. @LaurenByersMD @NIVokes John Heymach @MDAnder….
0
5
0
RT @VJOncology: 🌟 A remarkable oral session at #ASCO25 showcasing that the future of lung cancer care is bright!. 👏 Hats off to the incredi….
0
5
0
RT @RyanDenu: Great to meet with our lung cancer experts at @MDAndersonNews and thanks for the consult!.@lungoncdoc @NIVokes #ASCO2025 http….
0
4
0
Best way to start #ASCO25 Sunday is with new NSCLC data! Come by Arie Crown at 8 for exciting abstracts and discussion, cochairing with @BrunaPellini #LCSM
2
3
34
RT @lungoncdoc: Happening soon at #ASCO25!!. Dr. @BrunaPellini (@MoffittNews) and Dr. @NIVokes (@MDAndersonNews) will be chairing the metas….
0
6
0
RT @lungoncdoc: Come see us at #ASCO25 at the @MDAndersonNews Booth! . @NIVokes @FSkoulidis #EndCancer
0
2
0
RT @kyleconcannon4: Great chat with @NIVokes and @JJSingleton1 about immunotherapy. What it is and what it’s like to receive it from the ex….
0
3
0
RT @Cracking_Cancer: Confused about immunotherapy? Listen to @NIVokes and @JJSingleton1 getting into the nuts and bolts of how it works and….
0
3
0
RT @lungoncdoc: @MDAndersonNews thoracic oncology team does #TexasLung25! . @TLCconference #TinaCascone @StephenVLiu
0
2
0
RT @SWaliany: Great start to @TLCconference w/ talks on evolving landscape of 1L & 2L+ tx for pts w/ #EGFR-mutant #NSCLC.💠When to use upfro….
0
6
0
RT @drshieldsmd: Day 1 #TexasLung25 at Austin City Limits is underway! . Outstanding faculty discussion on WHO and WHEN to intensify therap….
0
6
0
RT @TLCconference: The treatment landscape for EGFR-mutant advanced NSCLC is shifting—are you up to date? At #TexasLung25, Dr. @karenkellym….
0
4
0
RT @TLCconference: The landscape for EGFR-mutant advanced NSCLC is evolving. At #TexasLung25, Dr. @NIVokes joins a panel to discuss the lat….
0
5
0
Thanks to @TargetedOnc for the invitation, had a great time reviewing this data! More nuanced clinical decisions to be made with our patients as our options for front-line EGFR have increased.
During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, (@NIVokes) discussed trials of targeted agents for EGFR+ lung cancer. #lcsm | @MDAndersonNews.
1
2
10
RT @thenasheffect: Had an awesome time at dinner conversations with folks on the @ASCO Lung scientific committee track @MMarmarelis @drshi….
0
6
0
RT @brainaddiction: It's clear that many do not understand what @NIH-funded research does to improve health. It's time to revive a study pu….
0
424
0
RT @drgandara: Huge disruption to heath care pending. Telehealth coverage will largely expire March 31 unless current administration revers….
gastroenterologyadvisor.com
The pandemic expansion of Medicare telehealth, set to expire March 31, has been extended until September 30, 2025.
0
22
0
RT @christine_lovly: Tackling big problems requires radical collaboration 💪. The “PoweRD 2 Cure” team strives to overcome minimal residual….
0
10
0
RT @break_cancer: Today we launch the PoweRD 2 Cure ALK+ Lung Cancer TeamLab! .Uniting researchers from @DanaFarber @MDAndersonNews @kochin….
0
12
0